SCHEMBL4623650

SCHEMBL4623650

CC(C)Cn1c(=O)n(CCO)c(=O)c2[nH]cnc21

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 9/20 0.80
ADORA2A P29274 8/20 0.80
PDE2A O00408 2/20 0.79
PDE1A P54750 2/20 0.79
PDE1B Q01064 2/20 0.79
PDE1C Q14123 2/20 0.79
PDE4A P27815 11/20 0.74
PDE4B Q07343 11/20 0.74
PDE4C Q08493 11/20 0.74
PDE4D Q08499 11/20 0.74
CFTR P13569 2/20 0.71
PDE5A O76074 1/20 0.71
CYP1A2 P05177 1/20 0.71
CYP3A4 P08684 1/20 0.71
TSHR P16473 1/20 0.71
MAPK1 P28482 1/20 0.71
ADORA1 P30542 1/20 0.71
SCN1A P35498 1/20 0.71
PDE6C P51160 1/20 0.71
PDE3B Q13370 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9430493 0.92 ADORA2A (0.76) ADORA2BADORA2APDE2APDE1APDE1B
SCHEMBL9430122 0.88 ADORA2B (0.85) ADORA2BADORA2APDE2APDE1APDE1B
SCHEMBL10579248 0.88 ADORA2B (1.00) ADORA2BADORA2APDE2APDE1APDE1B
SCHEMBL5405285 0.85 ADORA2A (0.86) ADORA2BADORA2APDE2APDE1APDE1B
SCHEMBL9430034 0.85 PDE4A (1.00) ADORA2BADORA2APDE4APDE4BPDE4C
Isobutylmethylxanthine SCHEMBL50315 0.83 PDE4A (1.00) ADORA2BADORA2APDE2APDE1APDE1B
Isobutylmethylxanthine SCHEMBL28814716 0.83 PDE4A (1.00) ADORA2BADORA2APDE2APDE1APDE1B
Isobutylmethylxanthine SCHEMBL7637581 0.81 PDE4A (0.94) ADORA2BADORA2APDE2APDE1APDE1B
SCHEMBL239725 0.81 CFTR (1.00) ADORA2BADORA2APDE2APDE1APDE1B
SCHEMBL11073850 0.81 ADORA2B (0.78) ADORA2BADORA2APDE2APDE1APDE1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0502043-B1 UTILIZATION OF XANTHINES, OPTIONALLY INCORPORATED IN LIPOSOMES IN ORDER TO HELP THE PIGMENTATION OF SKIN OR HAIR LVMH RECH (FR) 1995-03-01 EP claimed
EP-0269841-B1 1-HYDROXYALKYL XANTHINES, PROCESSES FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM SOCIETE DES PRODUITS NESTLE S.A. (CH) 1992-11-11 EP claimed
EP-0502043-A1 UTILIZATION OF XANTHINES, OPTIONALLY INCORPORATED IN LIPOSOMES IN ORDER TO HELP THE PIGMENTATION OF SKIN OR HAIR. LVMH RECH (FR) 1992-09-09 EP claimed
WO-1991007945-A1 UTILIZATION OF XANTHINES, OPTIONALLY INCORPORATED IN LIPOSOMES IN ORDER TO HELP THE PIGMENTATION OF SKIN OR HAIR LVMH RECHERCHE (FR) 1991-06-13 WO claimed
EP-0269841-A1 1-Hydroxyalkyl xanthines, processes for their preparation and medicaments containing them SOCIETE DES PRODUITS NESTLE S.A. (CH) 1988-06-08 EP claimed
EP-1904020-A2 NEW SLIMMING COSMETIC COMPOSITIONS Sederma S.A.S. (FR) 2008-04-02 EP disclosed
WO-2007010478-A2 SLIMMING COSMETIC COMPOSITIONS SEDERMA (FR) 2007-01-25 WO disclosed
US-5470579-A Xanthines, optionally incorporated in liposomes, for promoting skin or hair pigmentation LVMH, RECHERCHE (FR) 1995-11-28 US disclosed
EP-0502043-B1 UTILIZATION OF XANTHINES, OPTIONALLY INCORPORATED IN LIPOSOMES IN ORDER TO HELP THE PIGMENTATION OF SKIN OR HAIR LVMH RECH (FR) 1995-03-01 EP disclosed
US-5338741-A Cardiotonic agents NESTEC S.A. (CH) 1994-08-16 US disclosed
EP-0269841-B1 1-HYDROXYALKYL XANTHINES, PROCESSES FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM SOCIETE DES PRODUITS NESTLE S.A. (CH) 1992-11-11 EP disclosed
EP-0502043-A1 UTILIZATION OF XANTHINES, OPTIONALLY INCORPORATED IN LIPOSOMES IN ORDER TO HELP THE PIGMENTATION OF SKIN OR HAIR. LVMH RECH (FR) 1992-09-09 EP disclosed
US-5053433-A Photodiesterase inhibitor SOCIETE ANONYME DITE: L'OREAL (FR) 1991-10-01 US disclosed
WO-1991007945-A1 UTILIZATION OF XANTHINES, OPTIONALLY INCORPORATED IN LIPOSOMES IN ORDER TO HELP THE PIGMENTATION OF SKIN OR HAIR LVMH RECHERCHE (FR) 1991-06-13 WO disclosed
EP-0269841-A1 1-Hydroxyalkyl xanthines, processes for their preparation and medicaments containing them SOCIETE DES PRODUITS NESTLE S.A. (CH) 1988-06-08 EP disclosed